Received Sep 17, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| FLU3 | INFLUENZA (SEASONAL) (FLULAVAL) | GLAXOSMITHKLINE BIOLOGICALS | UNK | — | — |
a patient was administered with a Flulaval expired dose; This non-serious case was reported by a physician via call center representative and described the occurrence of expired vaccine used in a patient who received Flu Seasonal TIV Quebec (FluLaval 2024-2025 season) (expiry date 30-JUN-2025) for prophylaxis. On 02-SEP-2025, the patient received FluLaval 2024-2025 season. On 02-SEP-2025, an unknown time after receiving FluLaval 2024-2025 season, the patient experienced expired vaccine used (Verbatim: a patient was administered with a Flulaval expired dose). The outcome of the expired vaccine used was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 02-SEP-2025 For vaccine detail only expiration date was provided from doctor of medicine's end. No patient demographics were obtained in this call. No further information was obtained in this call. The vaccine administration facility was the same as primary reporter.